FXN and Friedreich ataxia: The treatment of lymphoblasts obtained from FRDA patients was found to significantly increase frataxin gene and protein expression (Jasoliya et al., 2019) and also dose-dependently increase mitochondrial function in FRDA mouse models (Hui et al., 2020).